FSH, inhibin B not accurate predictors of sperm count in childhood cancer survivors

Serum levels of follicle-stimulating hormone (FSH) and inhibin B are not good predictors of sperm levels in male survivors of childhood cancer, according to a study published online Feb. 19 in the Journal of Clinical Oncology.

FDA Approves Vidaza for Rare Pediatric Blood Cancer

New molecular subset of pediatric liver cancer identified

Frozen testicular tissue still viable after two decades

Study identifies potential target for treating childhood blood cancer

RAI Treatment in DTC Survivors Associated With Increased Risk of Other Cancers

AYA cancer survivors at higher risk for death due to second primary cancers

Immunotherapy for kids: An option for childhood liver cancer?

Biological pathways found that drive genomic changes and bone metastasis in Ewing Sarcoma

Research reveals a therapeutic opportunity to prevent rhabdomyosarcoma recurrence

We may know why some childhood cancers resolve on their own

Recent Posts